TP53 and colorectal carcinoma: In the present study, we aimed to investigatethe effect of a noveltherapeutic strategy to fight MDR in CRC combining β-carotenewith 5-FU using nanoparticles as a drug delivery system in a modelof 5-FU-resistant CRC cell line deleted of p53 and stably silencedfor uL3.13,16